-
161
RET kinase inhibitors for -altered thyroid cancers
Published 2022-06-01“…The REarrangement during Transfection ( RET ) proto-oncogene is involved in the pathogenesis of various thyroid cancer subtypes. Mutations in RET give rise to both hereditary and sporadic medullary thyroid cancer (MTC). …”
Get full text
Article -
162
Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment
Published 2023-04-01Subjects: “…thyroid cancer…”
Get full text
Article -
163
Chromosomal rearrangements and the pathogenesis of differentiated thyroid cancer
Published 2011-12-01“…The majority of thyroid cancers arise from the follicular cells of the thyroid gland, which yield a wide variety of distinct morphotypes, ranging from relatively indolent lesions to the most malignant forms of cancer known. …”
Get full text
Article -
164
Molecular testing approaches in thyroid cancer diagnosis
Published 2020-12-01Subjects: “…thyroid cancer…”
Get full text
Article -
165
The Role of Cdk5 in Neuroendocrine Thyroid Cancer
Published 2016Get full text
Get full text
Article -
166
Recurrent and/or metastatic thyroid cancer: therapeutic options.
Published 2002“…Thyroid cancer is relatively rare, accounting for 0.5 - 10 cases per 100,000 individuals per year. …”
Journal article -
167
Long-Term Oncological Outcomes of Papillary Thyroid Cancer and Follicular Thyroid Cancer in Children: A Nationwide Population-Based Study
Published 2022-05-01Subjects: “…papillary thyroid cancer…”
Get full text
Article -
168
-
169
Targeted Therapy for Medullary Thyroid Cancer: A Review
Published 2017-10-01Subjects: “…medullary thyroid cancer…”
Get full text
Article -
170
Regulators of glucose uptake in thyroid cancer cell lines
Published 2020-06-01Subjects: “…Thyroid cancer…”
Get full text
Article -
171
SENTINEL LYMPH NODE CONCEPT IN DIFFERENTIATED THYROID CANCER
Published 2014-12-01Subjects: “…Differentiated thyroid cancer…”
Get full text
Article -
172
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
Published 2011-01-01“…Vandetanib was tested in two Phase II trials in the treatment of patients with medullary thyroid cancer at doses of 100 mg and 300 mg daily respectively. …”
Get full text
Article -
173
The importance of selected cell adhesion molecules in thyroid cancer
Published 2018-07-01Subjects: Get full text
Article -
174
Epigenetics modifications and therapeutic prospects in human thyroid cancer
Published 2012-03-01Subjects: Get full text
Article -
175
New opportunities for preoperative diagnosis of anaplastic thyroid cancer
Published 2021-04-01“…Background. Anaplastic thyroid cancer (ATC) is one of the most aggressive human tumors. …”
Get full text
Article -
176
Systemic immune inflammation index in differentiated thyroid cancers
Published 2022-04-01Get full text
Article -
177
Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics
Published 2017-10-01Subjects: “…thyroid cancer…”
Get full text
Article -
178
Extent of Surgery for Differentiated Thyroid Cancer: Recommended Guideline
Published 2011-01-01Get full text
Article -
179
A biomarker and molecular mechanism investigation for thyroid cancer
Published 2023-09-01Subjects: “…thyroid cancer…”
Get full text
Article -
180
Identification of crucial genes involved in thyroid cancer development
Published 2023-05-01“…Abstract Background A malignancy of the endocrine system, one of the most common types, is thyroid cancer. It is proven that children who receive radiation treatment for leukemia or lymphoma are at a heightened risk of thyroid cancer due to low-dose radiation exposure throughout childhood. …”
Get full text
Article